Victory Capital Management Inc Myriad Genetics Inc Transaction History

Victory Capital Management Inc

$99 Billion
Q3 2024

A detailed history of Victory Capital Management Inc transactions in Myriad Genetics Inc stock. As of the latest transaction made, Victory Capital Management Inc holds 57,630 shares of MYGN stock, worth $769,936. This represents 0.0% of its overall portfolio holdings.

Number of Shares

57,630

Previous 59,797 3.62%

Holding current value

$769,936

Previous $1.46 Million 7.87%

% of portfolio

0.0%

Previous 0.0%

25 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 05, 2024	SELL	$23.97 - $28.6 $51,942 - $61,976	-2,167 Reduced 3.62%	57,630 $1.58 Million
Q2 2024 Aug 05, 2024	SELL	$17.98 - $25.47 $67,964 - $96,276	-3,780 Reduced 5.95%	59,797 $1.46 Million
Q1 2024 May 03, 2024	SELL	$17.59 - $23.59 $369,565 - $495,625	-21,010 Reduced 24.84%	63,577 $1.36 Million
Q4 2023 Feb 05, 2024	BUY	$13.91 - $21.32 $339,209 - $519,909	24,386 Added 40.51%	84,587 $1.62 Million
Q3 2023 Nov 06, 2023	BUY	$15.99 - $23.22 $14,582 - $21,176	912 Added 1.54%	60,201 $965,000
Q2 2023 Jul 27, 2023	BUY	$17.56 - $23.76 $1,387 - $1,877	79 Added 0.13%	59,289 $1.37 Million
Q1 2023 May 02, 2023	BUY	$15.26 - $23.75 $3,753 - $5,842	246 Added 0.42%	59,210 $1.38 Million
Q4 2022 Feb 10, 2023	BUY	$14.51 - $20.99 $1,131 - $1,637	78 Added 0.13%	58,964 $855,000
Q4 2022 Feb 09, 2023	SELL	$14.51 - $20.99 $26,988 - $39,041	-1,860 Reduced 3.06%	58,886 $854,000
Q3 2022 Nov 02, 2022	BUY	$18.21 - $27.88 $180,260 - $275,984	9,899 Added 19.47%	60,746 $1.16 Million
Q2 2022 Aug 01, 2022	BUY	$16.45 - $25.88 $24,165 - $38,017	1,469 Added 2.98%	50,847 $924,000
Q1 2022 May 04, 2022	BUY	$22.67 - $28.01 $219,694 - $271,444	9,691 Added 24.42%	49,378 $1.01 Million
Q4 2021 Feb 07, 2022	BUY	$24.13 - $32.63 $341,318 - $461,551	14,145 Added 55.38%	39,687 $1.1 Million
Q3 2021 Nov 02, 2021	SELL	$29.97 - $36.66 $56,493 - $69,104	-1,885 Reduced 6.87%	25,542 $825,000
Q2 2021 Aug 03, 2021	BUY	$25.39 - $32.61 $197,508 - $253,673	7,779 Added 39.59%	27,427 $839,000
Q1 2021 May 04, 2021	BUY	$19.92 - $31.6 $178,044 - $282,440	8,938 Added 83.45%	19,648 $598,000
Q4 2020 Feb 01, 2021	BUY	$12.16 - $19.77 $130,233 - $211,736	10,710 New	10,710 $212,000
Q2 2020 Aug 07, 2020	SELL	$10.69 - $16.49 $173,199 - $267,170	-16,202 Closed	0 $0
Q1 2020 May 04, 2020	BUY	$9.78 - $29.53 $7,432 - $22,442	760 Added 4.92%	16,202 $232,000
Q4 2019 Feb 06, 2020	SELL	$20.93 - $35.1 $879,269 - $1.47 Million	-42,010 Reduced 73.12%	15,442 $420,000
Q4 2019 Feb 04, 2020	BUY	$20.93 - $35.1 $935,026 - $1.57 Million	44,674 Added 349.62%	57,452 $1.59 Million
Q3 2019 Nov 12, 2019	BUY	$22.08 - $47.08 $282,138 - $601,588	12,778 New	12,778 $366,000
Q3 2018 Nov 01, 2018	SELL	$37.57 - $50.34 $273,284 - $366,173	-7,274 Closed	0 $0
Q2 2018 Aug 02, 2018	BUY	$27.75 - $40.17 $27,750 - $40,170	1,000 Added 15.94%	7,274 $272,000
Q1 2018 May 04, 2018	BUY	$28.83 - $41.01 $180,879 - $257,296	6,274 New	6,274 $185,000

Others Institutions Holding MYGN

# of Institutions

253

Shares Held

90.5M

Call Options Held

100K

Put Options Held

34K

View Full List

About MYRIAD GENETICS INC

Ticker MYGN
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 80,634,800
Market Cap $1.08B
Description
Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in the United States and internationally. The company offers molecular diagnostic tests for use in oncology, and women's and mental health applications. It provides MyRisk Hereditary Cancer Test, a DNA sequencing test for assessing ...

More about MYGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Victory Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Victory Capital Management Inc with notifications on news.

Account

Victory Capital Management Inc Myriad Genetics Inc Transaction History